CYCLOBOND I 2000 is bonded with β-cyclodextrin by a patented process to produce a stable matrix with the cyclodextrin arranged in such a way as to retain its most valuable property of forming inclusion complexes. This allows them to effect numerous chemical separations by selectively including into their cavities a wide variety of organic molecules. Non-inclusion type separations are also possible with the polar organic mode for a wide variety of molecule types.
Journal of pharmaceutical and biomedical analysis, 9(10-12), 787-792 (1991-01-01)
The interaction of beta-cyclodextrin with a series of structurally related chiral thromboxane antagonists was investigated using NMR and RP-HPLC. HPLC studies used both a cyclodextrin bonded phase (Cyclobond I), and beta-cyclodextrin as a mobile phase additive with an achiral C8
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.